Search
for
Sort by
Research 121–150 of 1000+
- Erosive Pustular Dermatosis of the Scalp-Like Eruption due to Gefitinib: Case Report and Review of the Literature of Alopecia Associated with EGFR Inhibitors
- Epigen Transgenic Mice Develop Enlarged Sebaceous Glands
- Incidence and management of cutaneous toxicities associated with cetuximab
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- A Case of Cicatricial Alopecia Associated with Erlotinib
- Trichoscopic Findings of Erosive Pustular Dermatosis of the Scalp Associated with Gefitinib
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Skin toxicity caused by EGFR antagonists—An autoinflammatory condition triggered by deregulated IL‐1 signaling?
- Rash from EGFR inhibitors: Opportunities and challenges for palliation
- Dermatologic Reactions to Targeted Therapy
- Nrf2-Mediated Expansion of Pilosebaceous Cells Accelerates Cutaneous Wound Healing
- Brief Report: Requirement of TACE/ADAM17 for Hair Follicle Bulge Niche Establishment
- Regulation of Semaphorin3A in the process of cutaneous wound healing
- EGFR Controls Hair Shaft Differentiation in a p53-Independent Manner
- Cetuximab-induced hypertrichosis of the scalp and eyelashes
- Network pharmacology-based preventive effect of XZF on cutaneous toxicities induced by EGFR inhibitor
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- The Epithelial Stem Cell Niche in Skin
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Erlotinib-Associated Alopecia in a Lung Cancer Patient
- Novel Application of Layered Expression Scanning for Proteomic Profiling of Plucked Hair Follicles
- Histochemistry of the porcine pilosebaceous unit
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Regulation and Role of GLI1 in Cutaneous Squamous Cell Carcinoma Pathogenesis
- Periocular Manifestations of Afatinib Therapy
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Accelerative action of topical piperonylic acid on mice full thickness wound by modulating inflammation and collagen deposition
- “PRIDE” Complex
- Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers